Repare Therapeutics Inc.
RPTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $76 | $60 | $42 | $56 |
| - Cash | $73 | $68 | $84 | $85 |
| + Debt | $0 | $1 | $1 | $2 |
| Enterprise Value | $3 | -$7 | -$41 | -$27 |
| Revenue | $12 | $0 | $0 | $0 |
| % Growth | 4,548% | – | – | – |
| Gross Profit | $12 | $0 | -$1 | -$0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | $3 | -$19 | -$28 | -$28 |
| % Margin | 29.9% | -7,610.4% | – | – |
| Net Income | $3 | -$17 | -$30 | -$29 |
| % Margin | 28% | -6,697.6% | – | – |
| EPS Diluted | 0.08 | -0.39 | -0.71 | -0.67 |
| % Growth | 120.5% | 45.1% | -6% | – |
| Operating Cash Flow | $3 | -$16 | -$29 | -$27 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $3 | -$16 | -$29 | -$27 |